MARATTO

article · Bangladesh Journal of Medical Science

Risk factors associated with the age onset of the first psychosis episode in schizophrenia of Moroccan patients: retrospective study on the role of the prodromal signs, family psychosis, and cannabis

2026Open accessIbn Tofail University

Abstract

Background Prodromal signs are a valuable factor, but they can be challenging to serve as predictive indicators in schizophrenia; meanwhile, other significant risk factors, like family history and cannabis use, are well-documented high-risk factors. Aim This present study aimed to examine the association between the age at onset of psychosis and prodromal signs, family history of psychosis, and cannabis use independently, as well as the impact of their interaction. Methods Our study employed a retrospective approach and recruited 200 Moroccan patients clinically diagnosed with schizophrenia with a mean age of 31.47 years (± 8.39) from the Ar-razi Psychiatric Center of ibn Sina Hospital. Clinical data were collected in the presence of a qualified psychiatrist via a structured questionnaire. Results we found that the more prodromal signs a patient had, the age at onset of psychosis was slightly lowered with a non-significant small effect [E= -0.04; CI(-0.69) – (0.61); p= 0.89], similarly effect was observed to the presence of family psychosis [E= -0.12; CI(-1.79) – (1.53); p= 0.87], however the cannabis users patients showed a statistically significant association with an earlier age at onset of psychosis by lowering it 2 years compared to non-cannabis users [E= -2.23; CI(-4.28) – (-0.18); p= 0.03], their interaction had also a small effect at the age at onset of psychosis by the presence of prodromal signs. Conclusion cannabis use was associated with an early age at onset of psychosis, and this trend was consistent among patients who exhibited more prodromal signs. Even though other risk factors were non-significant, they also had a small effect influenced by the presence of prodromal signs. BJMS, Vol. 25 No. 01 January’26 Page : 206-213

Research topics

  • Schizophrenia research and treatment
  • Cannabis and Cannabinoid Research
  • Bipolar Disorder and Treatment

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3329/bjms.v25i1.86420

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.